Blood cancer research and treatment in Dallas

The Blood Cancer Research and Treatment Center at Baylor Scott & White Charles A. Sammons Cancer Center – Dallas is one of few specialized centers nationally.

The center combines the expertise of a multidisciplinary physician team on the medical staff at Baylor University Medical Center, part of Baylor Scott & White Health, to provide a premier destination for the diagnosis, evaluation, research and treatment of blood cancers in Dallas. We are dedicated to offering the most advanced therapies, innovative research and valuable patient-centered resources to those diagnosed with a hematological malignancy.

Patient support and education

A patient navigator is ready to connect with you

Our patient navigator will work with you to provide comprehensive and personalized cancer care.

Contact a patient navigator

Types of blood cancer treated

​​​​​​​​​​​​​

The specialists at the Blood Cancer Research and Treatment Center use advanced techniques to provide expert care for blood cancers.

Acute lymphocytic leukemia (ALL)

Leukemia is when abnormal cells grow rapidly in the bone marrow.

Acute lymphocytic leukemia is a type of leukemia that starts in early forms of lymphocytes, called lymphoblasts.

As these blasts grow, the can crowd out the normal cells in the bone marrow.

Acute myeloid leukemia (AML)

Leukemia is when abnormal cells grow rapidly in the bone marrow.

Acute myeloid leukemia is when leukemia starts in the early forms of myelocytes, called myeloblasts.

These white blood cells that don't fight infection overcrowd the ones that do, pushing them out of the blood.

Chronic lymphocytic leukemia

Chronic lymphocytic leukemia is a slowly progressing disease in which abnormal lymphocytes crowd out other blood cells and may collect in the blood, bone marrow and lymph tissues.

Chronic myelogenous leukemia

Chronic myeloid leukemia is when leukemia starts in the early forms of myelocytes. It starts in cells that normally help the body fight infections.

This is an uncommon form of leukemia and is slow moving.

Lymphoma (Hodgkin's and non-Hodgkin's)

Lymphoma is when the body starts making cells that are not needed in the lymphatic system.

Hodgkin's lymphoma spreads in a predictable pattern and can spread to other organs in the body. These cancer cells only make up a small part of the cells in a cancerous lymph node.

Mantle cell lymphoma

Lymphoma is when the body starts making cells that are not needed in the lymphatic system.

Lymphoma is divided into two major categories:

  • Hodgkin lymphoma (HL)
  • Non-Hodgkin lymphoma (NHL)

Mantle cell lymphoma is a type of non-Hodgkin's lymphoma.

Lymphoma may arise in any one of three types of lymphocytes:

  • B lymphocytes (B cells)
  • T lymphocytes (T cells)
  • Natural killer (NK) cells

Mantle cell lymphoma results from a malignant transformation of a B lymphocyte.

Multiple myelomas

Multiple myeloma is a rare cancer that begins in a type of white blood cell called the plasma cell. When these cells become abnormal and grow rapidly, it turns into cancer.

Plasma cells are found in the bone marrow and the outer layer of the bones.

Multiple myeloma is not a bone cancer but is cancer that affects bones.

Myelodysplastic syndrome (MDS)

Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature, so do not become healthy blood cells.

MDS is often referred to as a "bone marrow failure disorder".

Myeloproliferative neoplasms

Myeloproliferative neoplasms (MPNs) are blood cancers that occur when the body makes too many white or red blood cells, or platelets.

This overproduction of blood cells in the bone marrow can create problems for blood flow and lead to various symptoms.

Plasma cell dyscrasias

Plasma cell dyscrasias are a heterogeneous group of disorders caused by the monoclonal proliferation of lymphoplasmacytic cells in the bone marrow.

Multiple myeloma is the most serious and prevalent plasma cell dyscrasias.

Diagnostic and treatment approach

From diagnosis to survivorship, and everything in between, Baylor Scott & White Charles A. Sammons Cancer Center – Dallas is by your side.

At Sammons Cancer Center – Dallas, we are pleased to offer advanced technology and methodology for diagnosing hematologic malignancies. Treatment and care plans for patients are based on medical history; type and molecular characteristics of hematologic malignancy; and the patient's personal preferences. Treatment options include:

With many blood cancer treatments requiring an inpatient hospital stay, patient-centered care and comprehensive support services are of utmost importance. Sammons Cancer Center – Dallas is pleased to offer a comprehensive patient support center adjacent to the Baylor Scott & White T. Boone Pickens Cancer Hospital where patients can enjoy everything from music therapy to cooking demonstrations. Additionally, we understand the need to have loved ones involved throughout the course of treatment, and for that reason, our spacious hospital rooms are specially equipped to accommodate family members staying overnight with patients.

Specially trained genetic counselors can help assess your likelihood of having an increased risk to develop certain types of cancer.
190924_0922.jpg

Texas Immuno-Oncology Biorepository (TIOB)

The Texas Immuno-Oncology Biorepository (TIOB) is a research facility that collects, catalogs and stores samples of biological material, such as urine, blood, stool, tissue, cells, DNA, RNA and protein, in an effort to improve our understanding of cancer.

Learn more about TIOB

Our team approach

Every patient is unique and deserves a personalized plan of care. Our multidisciplinary team of experts participate in monthly cancer conferences where they discuss, evaluate and recommend the best course of treatment for every patient. In every facet of care, our team is uniquely and specially trained to treat and support patients with leukemia and other hematologic malignancies (blood cancers). The care team at the Blood Cancer Research and Treatment Center includes specialists in the fields of:

Medical Leadership

1144263633.jpg

Luis Pineiro, MD

Medical Director, Blood and Marrow Transplant Program

View full profile

1508815234.jpg

John R. Krause, MD

Medical Director, Hematopathology

View full profile

1518059807.jpg

M. Yair Levy, MD

Medical Director, Hematologic Malignancy Research

View full profile

1871535823.jpg

Robert Berryman, MD

Medical Director, Blood and Marrow Transplant Outreach Program

View full profile